Inotuzumab Ozogamicin Hoʻokomo

Anter

• Ma mua o ka hoʻohana ʻana i ka inotuzumab ozogamicin injection,
• Inotuzumab ozogamicin injection hiki ke hopena i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:
• Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli a i ʻole nā ​​mea i helu ʻia i ka ʻARlelo AOAO IMAHI a i ʻole KĀʻĀLĀ ʻĀpana, e kāhea koke aku i kāu kauka a i ʻole e kiʻi i nā lāʻau lapaʻau pilikia.

Inotuzumab ozogamicin injection hiki ke hōʻeha i ke ola a weliweli paha i ke ola, e like me ka maʻi hepatic veno-occlusive (VOD; nā kīʻaha koko i hoʻopaʻa ʻia i loko o ke ake). E haʻi i kāu kauka inā loaʻa a loaʻa paha ʻoe i ka maʻi ate a i ʻole he hemoopopoicicic trans-cell transplant (HSCT; ke kaʻina hana e lawe ʻia ai kekahi mau hunaola mai ke kino a hoʻi hou i ke kino). Inā ʻike ʻoe i kekahi o kēia mau ʻōuli, e kāhea koke aku i kāu kauka: loaʻa wikiwiki, ʻeha a pehu paha ma ka ʻaoʻao ʻākau i luna o ka ʻōpū, melemele o ka ʻili a i ʻole nā ​​maka, nausea, luaʻi, mimi ʻeleʻele, a i ʻole ka luhi nui.

Inotuzumab ozogamicin injection hiki ke hoʻonui i ka makaʻu o ka make, ʻaʻole no ka hoʻi ʻana o ka leukemia, ma hope o ka loaʻa ʻana iā HSCT. Inā ʻoe e ʻike i kekahi o nā ʻōuli ma hope o ka HSCT ke loaʻa iā ʻoe ka inotuzumab ozogamicin injection, e kāhea koke aku i kāu kauka: fiva, batukū, ʻāʻī puʻuwai, haʻalulu, a me nā hōʻailona ʻino ʻē aʻe; ke kaupaona wikiwiki ʻana, a i ʻole ka ʻeha a i ʻole ka pehu ʻana ma ka ʻaoʻao ʻākau ma luna o ka ʻōpū.

E mālama i nā manawa a pau me kāu kauka a me ka hale hana. E kauoha kāu kauka i kekahi mau hoʻokolohua ma mua, i ka wā, a ma hope o kāu mālama ʻana e nānā i ka pane o kou kino i ka inotuzumab ozogamicin.

Hoʻohana ʻia ka inotuzumab ozogamicin injection e mālama ai i kekahi leukemia lymphoblastic koʻikoʻi (ALL; kahi ʻano o ka maʻi ʻaʻai e hoʻomaka i loko o nā keʻokeʻo keʻokeʻo) i nā mākua i pane ʻole i nā mālama maʻi maʻi mua. ʻO ka inotuzumab ozogamicin injection i loko o ka papa o nā lāʻau i kapa ʻia he monoclonal antibodies. Hana ia ma ka hoʻoulu ʻana i ka ʻōnaehana pale e luku ai i nā hunaola maʻi ʻaʻai.

ʻO ka inotuzumab ozogamicin injection e hele mai me he lepo lā e hui ʻia me ka wai e hoʻokomo ʻia i loko o ke aniani (i kahi aa) e ke kauka a kahu wahine paha i kahi haukapila a i ʻole kahi wahi olakino. Hoʻokomo pinepine ʻia ia i nā lā 1, 8, a me 15 o ke kaʻina 3 a i 4 mau pule. E hana hou ʻia ke pōʻaiapuni i kēlā me kēia 4 pule e like me ka ʻōlelo a kāu kauka. Aia ka lōʻihi o kāu mālama ʻana i ka maikaʻi o ka pane ʻana o kou kino i ka lāʻau a me nā hopena ʻaoʻao āu e ʻike ai.

Pono paha kāu kauka e hoʻopau a hoʻopau paha i kāu lāʻau lapaʻau, hoʻohaʻahaʻa i kāu lāʻau, a mālama iā ʻoe me nā lāʻau hou, e like me kāu pane i ka inotuzumab ozogamicin a me nā hopena ʻē aʻe āu e ʻike ai. E loaʻa iā ʻoe kekahi mau lāʻau e kōkua i ka pale ʻana i kahi hopena ma mua o kou loaʻa ʻana i kēlā me kēia lāʻau o inotuzumab ozogamicin. E haʻi i kāu kauka a kahu hānai inā ʻike ʻoe i kekahi o nā ʻōuli ma hope a i hoʻokahi hola paha ma hope o ka pau ʻana o ka infusion: fever, chills, rash, shortness of breath, a paʻakikī hoʻi i ka hanu E kamaʻilio me kāu kauka e pili ana i kou ʻano i ka manawa a ma hope o kāu lapaʻau.

Kau ʻia kēia lāʻau no nā hoʻohana ʻē aʻe; e noi i kāu kauka a kauka paha no ka ʻike hou aku.

Ma mua o ka hoʻohana ʻana i ka inotuzumab ozogamicin injection,

• e haʻi i kāu kauka a me ka kauka inā he maʻi ʻoe i ka inotuzumab ozogamicin, i nā lāʻau ʻē aʻe, a i ʻole kekahi o nā mea hana i ka inotuzumab ozogamicin injection. E noi i kāu kauka lāʻau no kahi papa inoa o nā mea hoʻohui.
• e haʻi i kāu kauka a me ka mea kauka lāʻau i nā lāʻau lapaʻau, nā wikamina, nā mea hoʻopihapiha, a me nā huahana lāʻau āu e lawe nei a hoʻolālā paha e lawe. E ʻike pono i kekahi o kēia mau mea: amiodarone (Pacerone, Nexterone); chloroquine (Aralen); clarithromycin (Biaxin, i Prevpac); disopyramide (Norpace); erythromycin (E.E.S., E-Mycin, P.C.E, nā mea ʻē aʻe); haloperidol; methadone (Dolophine, Methadose); nefazodone; pimozide (Orap); procainamide; quinidine (i Nuedexta); sotalol (Betapace, Betapace AF, Sorine); a me thioridazine. Pono paha kāu kauka e hoʻololi i nā kaha o kāu mau lāʻau a nānā pono iā ʻoe no nā hopena ʻaoʻao. Hiki paha i nā lāʻau ʻē aʻe ke launa pū me inotuzumab ozogamicin, no laila e ʻike pono i kāu kauka e pili ana i nā lāʻau a pau āu e lawe nei, a ʻo nā mea hoʻi i hōʻike ʻole ʻia ma kēia papa inoa.
• e haʻi i kāu kauka inā ʻo ʻoe a i ʻole kekahi o kou ʻohana a i ʻole loaʻa i kahi wā QT hoʻolōʻihi (kahi pilikia puʻuwai laha ʻole e hoʻonāukiuki ai i ka puʻuwai ʻole, maʻule paha, a make koke paha). Eia kekahi, e haʻi i kāu kauka inā loaʻa iā ʻoe a i ʻole loaʻa i kahi pae haʻahaʻa o ka potassium a me ka magnesium i loko o kou koko a maʻi maʻi maʻi paha.
• e haʻi i kāu kauka inā hāpai ʻoe a i ʻole hoʻolālā e hāpai. Inā he wahine ʻoe, ʻaʻole pono ʻoe e hāpai i ka wā e loaʻa ana iā ʻoe ka inotuzumab ozogamicin a no 8 mau mahina ma hope o kāu hopena hope loa. E kamaʻilio me kāu kauka e pili ana i nā hana kaohi hānau e holo pono nāu. Inā he kāne ʻoe, pono ʻoe a me kāu pakanā wahine e hoʻohana i ka kaohi hānau i ka wā o kāu mālama ʻana a hoʻomau i ka hoʻohana ʻana i ka kaohi hānau no 5 mau mahina ma hope o kāu hopena hope loa. Inā hāpai ʻoe a ʻo kāu hoa paha i ka loaʻa ʻana o ka inotuzumab ozogamicin, e kāhea i kāu kauka. Hiki i nā Inotuzumab ozogamicin ke hōʻeha i ka fetus.
• e haʻi i kāu kauka inā e hānai ana ʻoe i ka waiū. E haʻi paha kāu kauka iā ʻoe ʻaʻole e hānai i ka wā o kāu mālama ʻana me ka inotuzumab ozogamicin injection a no 2 mau mahina ma hope o kāu hopena hope loa.
• pono ʻoe e ʻike i kēia lāʻau i hoʻemi ai i ka momona i nā kāne a me nā wahine. E kamaʻilio me kāu kauka e pili ana i nā pilikia o ka loaʻa ʻana o ka inotuzumab ozogamicin.

Inā ʻaʻole haʻi kāu kauka iā ʻoe, e hoʻomau i kāu papaʻai maʻamau.

Inotuzumab ozogamicin injection hiki ke hopena i nā hopena ʻaoʻao. E haʻi i kāu kauka inā koʻikoʻi kekahi o kēia mau ʻōuli a mai hele aku paha:

• ʻūpā
• ʻālohilohi

Hiki i kekahi o nā hopena ʻaoʻao ke koʻikoʻi. Inā ʻike ʻoe i kekahi o kēia mau ʻōuli a i ʻole nā ​​mea i helu ʻia i ka ʻARlelo AOAO IMAHI a i ʻole KĀʻĀLĀ ʻĀpana, e kāhea koke aku i kāu kauka a i ʻole e kiʻi i nā lāʻau lapaʻau pilikia.

• ke kuni, ke anu, ka ʻū, a i ʻole nā ​​hōʻailona ʻē aʻe o ka maʻi
• kahe koko ʻole ʻana a palapū paha
• pahu noho ʻeleʻele a lohi hoʻi
• koko ʻulaʻula i nā noho
• ʻili mae
• luhi

Inotuzumab ozogamicin injection hiki ke kumu i nā hopena ʻē aʻe. Kāhea i kāu kauka inā loaʻa iā ʻoe kekahi pilikia maʻamau i ka loaʻa ʻana o kēia lāʻau.

Inā ʻoe e ʻike i kahi hopena koʻikoʻi, e hoʻouna ʻoe a i ʻole kāu kauka i kahi hōʻike i ka papahana hōʻike ʻino a MedWatch Adverse Event Food (FDA) ma ka pūnaewele (http://www.fda.gov/Safety/MedWatch) a i ʻole kelepona. 1-800-332-1088).

E nīnau i kāu kauka lāʻau i nā nīnau āu e pili ana i ka inotuzumab ozogamicin injection.

He mea nui iā ʻoe e mālama i kahi papa inoa i kākau ʻia a me nā lāʻau lapaʻau ʻole (over-the-counter) lāʻau āu e lawe nei, a me nā huahana e like me nā huaora, nā minelala, a i ʻole nā ​​mea hoʻopiliʻai aʻe. Pono ʻoe e lawe i kēia papa inoa me ʻoe i kēlā me kēia manawa ke kipa ʻoe i ke kauka a i ʻole inā ʻae ʻia ʻoe i kahi haukapila. He ʻike nui nō hoʻi ia e lawe pū me ʻoe inā pilikia ʻo ka pilikia.

• Besponsa^®